These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 517534)
21. Relationship between length of time and contamination in open intravenous solutions. Amonsen S; Gren JE Nurs Res; 1978; 27(6):372-4. PubMed ID: 251249 [TBL] [Abstract][Full Text] [Related]
22. Bretylium tosylate intravenous admixture compatibility. I: Stability in common large-volume parenteral solutions. Lee YC; Baaske DM; Amann AH; Carter JE; Mooers MA; Wagenknecht DM; Lai CM Am J Hosp Pharm; 1980 Jun; 37(6):803-8. PubMed ID: 7395875 [TBL] [Abstract][Full Text] [Related]
23. Evaluation of three methods for detecting bacterial contamination in intravenous solutions. Hoffman KH; Smith FM; Godwin HN; Hogan LC; Furtado D Am J Hosp Pharm; 1982 Aug; 39(8):1299-302. PubMed ID: 6751078 [TBL] [Abstract][Full Text] [Related]
24. Assuring the quality of intravenous admixture programs. Stolar MH Am J Hosp Pharm; 1979 May; 36(5):605-8. PubMed ID: 453213 [TBL] [Abstract][Full Text] [Related]
25. Sterility testing of a total nutrient admixture with a biphasic blood-culture system. Murray PR; Sandrock MJ Am J Hosp Pharm; 1991 Nov; 48(11):2419-21. PubMed ID: 1746575 [TBL] [Abstract][Full Text] [Related]
26. Compatibility of aminophylline and methylprednisolone sodium succinate intravenous admixtures. Johnson CE; Cohen IA; Craft DA; Lizer MH Am J Hosp Pharm; 1986 Jun; 43(6):1482-5. PubMed ID: 3524206 [TBL] [Abstract][Full Text] [Related]
27. Premixed intravenous admixtures: a critical challenge for hospital pharmacy. Loeb AJ; Fishman DA; Kochis TR Am J Hosp Pharm; 1983 Jun; 40(6):1041-3. PubMed ID: 6869392 [TBL] [Abstract][Full Text] [Related]
28. [Evaluation of a new intravenous device]. Lustig A; Yofee A; Sokol R Harefuah; 1993 Sep; 125(5-6):133-5, 192. PubMed ID: 8225089 [TBL] [Abstract][Full Text] [Related]
29. Comparison of automated culture systems with a CFR/USP-compliant method for sterility testing of cell-therapy products. Khuu HM; Stock F; McGann M; Carter CS; Atkins JW; Murray PR; Read EJ Cytotherapy; 2004; 6(3):183-95. PubMed ID: 15203975 [TBL] [Abstract][Full Text] [Related]
30. Sterility of total parenteral nutrient solutions stored at room temperature for seven days. Takagi J; Khalidi N; Wolk RA; Tjolsen E; de Leon R; Wesley JR Am J Hosp Pharm; 1989 May; 46(5):973-7. PubMed ID: 2499191 [TBL] [Abstract][Full Text] [Related]
31. Word-processing system in a centralized intravenous admixture program. Kirschenbaum BE Am J Hosp Pharm; 1982 Oct; 39(10):1690-2. PubMed ID: 6816065 [TBL] [Abstract][Full Text] [Related]
32. Temperature of refrigerated i.v. fluids and admixtures during infusion. Stiles ML; Mickschl D; Thompson DF Am J Hosp Pharm; 1989 May; 46(5):977-9. PubMed ID: 2499192 [TBL] [Abstract][Full Text] [Related]
33. Concentration-time profile of phenytoin after admixture with small volumes of intravenous fluids. Cloyd JC; Bosch DE; Sawchuk RJ Am J Hosp Pharm; 1978 Jan; 35(1):45-8. PubMed ID: 623117 [TBL] [Abstract][Full Text] [Related]
34. Studies on microbial contamination of infusion fluids arising from drug additions and administration. Ernerot L; Thorén S; Sandell E Acta Pharm Suec; 1973 May; 10(2):141-6. PubMed ID: 4728099 [No Abstract] [Full Text] [Related]
35. Quality of intravenous infusion fluids manufactured in Kenya. Aluoch-Orwa JA; Ondari CO; Kibwage IO; Hoogmartens J East Afr Med J; 1995 Dec; 72(12):800-4. PubMed ID: 8689981 [TBL] [Abstract][Full Text] [Related]
36. Compatibility and stability of labetalol hydrochloride in commonly used intravenous solutions. Yuen PH; Taddei CR; Wyka BE; Chaudry IA Am J Hosp Pharm; 1983 Jun; 40(6):1007-9. PubMed ID: 6869384 [TBL] [Abstract][Full Text] [Related]